{"title":"【慢性心力衰竭门诊用药干预分析】。","authors":"Elisée Doffou, Aminata Coulibaly, Pascal Danho Abrogoua","doi":"10.1016/j.pharma.2025.01.004","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Our aim was to analyze pharmaceutical interventions related to heart failure (HF) outpatient treatment.</p><p><strong>Methods: </strong>An observationnal study was carried out over 6 months at the Abidjan Institute of Cardiology (ICA). Data were collected using a survey form that focused on therapeutic adherence, drugs related-problems (DRP) and pharmaceutical interventions (PI). DRP and PI coding tool of French Society of Clinical Pharmacy was used. Therapeutic adherence was assessed using the GIRERD tool. Prescription review made by Algorithm of Calop. Clinical, economic and organizational impacts of PI accepted by the physician were rated using the CLEO tool.</p><p><strong>Results: </strong>Study population had a mean age of 51.4 years. DRP prevalence was 59%. These DRP were essentially adherence problem (43%) and drug-drug interactions (39.7%). The PIs were mainly \"optimization of administration methods\" (43.6%) and \"therapeutic monitoring\" (38.1%). The acceptance rate of PIs intended for prescribers was 80.8%. Mainly of these PIs were rated \"PI with minor clinical impact\" (60.2%), \"PI without economic impact\" (83.8%) and PI with \"positive organizational impact\" (63.2%).</p><p><strong>Conclusion: </strong>DRPs and more specifically adherence problems and drug-drug interactions are common in HF outpatient management. The pharmacist can contribute to improve this care through regular assessment of therapeutic adherence and management of DRPs.</p>","PeriodicalId":8332,"journal":{"name":"Annales pharmaceutiques francaises","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Analysis of pharmaceutical interventions related to outpatient treatment of chronic heart failure].\",\"authors\":\"Elisée Doffou, Aminata Coulibaly, Pascal Danho Abrogoua\",\"doi\":\"10.1016/j.pharma.2025.01.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Our aim was to analyze pharmaceutical interventions related to heart failure (HF) outpatient treatment.</p><p><strong>Methods: </strong>An observationnal study was carried out over 6 months at the Abidjan Institute of Cardiology (ICA). Data were collected using a survey form that focused on therapeutic adherence, drugs related-problems (DRP) and pharmaceutical interventions (PI). DRP and PI coding tool of French Society of Clinical Pharmacy was used. Therapeutic adherence was assessed using the GIRERD tool. Prescription review made by Algorithm of Calop. Clinical, economic and organizational impacts of PI accepted by the physician were rated using the CLEO tool.</p><p><strong>Results: </strong>Study population had a mean age of 51.4 years. DRP prevalence was 59%. These DRP were essentially adherence problem (43%) and drug-drug interactions (39.7%). The PIs were mainly \\\"optimization of administration methods\\\" (43.6%) and \\\"therapeutic monitoring\\\" (38.1%). The acceptance rate of PIs intended for prescribers was 80.8%. Mainly of these PIs were rated \\\"PI with minor clinical impact\\\" (60.2%), \\\"PI without economic impact\\\" (83.8%) and PI with \\\"positive organizational impact\\\" (63.2%).</p><p><strong>Conclusion: </strong>DRPs and more specifically adherence problems and drug-drug interactions are common in HF outpatient management. The pharmacist can contribute to improve this care through regular assessment of therapeutic adherence and management of DRPs.</p>\",\"PeriodicalId\":8332,\"journal\":{\"name\":\"Annales pharmaceutiques francaises\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-01-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annales pharmaceutiques francaises\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.pharma.2025.01.004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales pharmaceutiques francaises","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.pharma.2025.01.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
[Analysis of pharmaceutical interventions related to outpatient treatment of chronic heart failure].
Objective: Our aim was to analyze pharmaceutical interventions related to heart failure (HF) outpatient treatment.
Methods: An observationnal study was carried out over 6 months at the Abidjan Institute of Cardiology (ICA). Data were collected using a survey form that focused on therapeutic adherence, drugs related-problems (DRP) and pharmaceutical interventions (PI). DRP and PI coding tool of French Society of Clinical Pharmacy was used. Therapeutic adherence was assessed using the GIRERD tool. Prescription review made by Algorithm of Calop. Clinical, economic and organizational impacts of PI accepted by the physician were rated using the CLEO tool.
Results: Study population had a mean age of 51.4 years. DRP prevalence was 59%. These DRP were essentially adherence problem (43%) and drug-drug interactions (39.7%). The PIs were mainly "optimization of administration methods" (43.6%) and "therapeutic monitoring" (38.1%). The acceptance rate of PIs intended for prescribers was 80.8%. Mainly of these PIs were rated "PI with minor clinical impact" (60.2%), "PI without economic impact" (83.8%) and PI with "positive organizational impact" (63.2%).
Conclusion: DRPs and more specifically adherence problems and drug-drug interactions are common in HF outpatient management. The pharmacist can contribute to improve this care through regular assessment of therapeutic adherence and management of DRPs.
期刊介绍：
This journal proposes a scientific information validated and indexed to be informed about the last research works in all the domains interesting the pharmacy. The original works, general reviews, the focusing, the brief notes, subjected by the best academics and the professionals, propose a synthetic approach of the last progress accomplished in the concerned sectors. The thematic Sessions and the – life of the Academy – resume the communications which, presented in front of the national Academy of pharmacy, are in the heart of the current events.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
